Huntsman Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Huntsman Corporation and Huntsman International LLC on June 22, 2007. The filing details the entry into a material definitive agreement regarding the sale of specific business assets.
Key Financial Metrics and Transaction Details
- Transaction Type: Sale of U.S. base chemicals and polymers business assets to Flint Hills Resources, LP and Flint Hills Resources, LLC.
- Polymers Business Sale Price: $150 million plus the value of associated inventory.
- Base Chemicals Business Sale Price: $306 million plus the value of associated inventory.
- Total Consideration: $456 million plus associated inventory values.
- Impairment Charge: Expected impairment charge of between $250 million and $270 million for the quarter ended June 30, 2007.
Material Changes and Closing Conditions
The filing amends an original agreement dated February 15, 2007. Key changes include:
- Polymers Closing: Scheduled to occur on or about August 1, 2007.
- Base Chemicals Closing: Scheduled to occur separately following the re-start of the Port Arthur, Texas olefins manufacturing facility.
- Financial Impact: The company expects to record a loss on disposal and a significant impairment charge in the second quarter of 2007.
Outlook, Risks, and Management Commentary
Management has concluded that an impairment charge is necessary in connection with the sale of the U.S. polymers business. The filing does not provide specific guidance on future revenue or earnings beyond the transaction details. The closing of the base chemicals portion of the deal is contingent upon the operational re-start of the Port Arthur facility, representing a key execution risk.
Investor Verification Checklist
- Verify the exact closing date for the polymers business sale (targeted for August 1, 2007).
- Monitor the status of the Port Arthur, Texas olefins manufacturing facility re-start, as it is a condition precedent for the base chemicals sale.
- Review the Q2 2007 earnings release for the final recorded impairment charge within the $250 million to $270 million range.
- Confirm the final valuation of associated inventory included in the sale price.